Sign in

Islam Elkholi

@iselkholi.bsky.social
84 followers 70 following 28 posts

MD, PhD|Oncology Research Fellow, McGill U.| Metastasis, Dormancy & Targeted Therapies|Writing|Coffee|Jazz/blues |🇪🇬➡️🇨🇦 Views are my own.

PostsRepliesMedia
Islam Elkholi @iselkholi.bsky.social · 16/11/2025
Heading to the @ccsresearch.bsky.social IGNITE Summit in Toronto. Looking forward to connecting with CCS awardees from across Canada and engaging in needed discussion about diversity in oncology! #CancerResearch
031
Islam Elkholi @iselkholi.bsky.social · 03/11/2025
Looking forward to sharing our work in this meeting!
021
Islam Elkholi @iselkholi.bsky.social · 13/09/2025
Stuck at home? Time to revisit the record collection! A record I caught this year in Chicago…
000
Islam Elkholi @iselkholi.bsky.social · 29/08/2025
It has been fun editing this issue focused on Cell Signaling in JoVE! Check this protocol by Vianney and Lee on proximity labelling in Drosophila melanogaster. app.jove.com/v/68193/in-v...
app.jove.com
<em>In Vivo</em> Application of TurboID-based Proximity Labeling in <em>Drosophila melanogaster</em>
Proximity labeling (PL) is a powerful method for mapping protein-protein interaction networks. Advances in labeling enzymes, especially TurboID, have ...
000
Islam Elkholi @iselkholi.bsky.social · 21/08/2025
CIHR will finally allow international PhD students to apply! A big step forward!
000
Reposted by Islam Elkholi
Nature Reviews Cancer @natrevcancer.nature.com · 14/08/2025
NEW content online!
nature.com
Ageing, immune fitness and cancer
Nature Reviews Cancer, Published online: 14 August 2025; doi:10.1038/s41568-025-00858-zAgeing reshapes immune composition, function and regenerative capacity, with profound effects on tumour immunity, cancer progression and treatment outcomes. In this Review, Dolan and colleagues examine how age-resolved immunoprofiling, insights from ageing haematopoiesis and preclinical modelling are uncovering immune ageing dynamics and therapeutic challenges — revealing new opportunities to optimize cancer therapy across diverse age groups.
061
Reposted by Islam Elkholi
Aguirre-Ghiso Lab @jaguirreghisolab.bsky.social · 12/08/2025
Thrilled to share our first clinical trial paper on prostate cancer cell dormancy induction using an epigenetic and differentiation strategy. This was a strong team effort between physicians and basic scientists leading to this innovative clinical trial. www.medrxiv.org/content/10.1...
medrxiv.org
A Pilot Study of the Combination of 5-Azacitidine and All-trans Retinoic Acid in Biochemically Recurrent Prostate Cancer.
Purpose: Biochemical recurrence (BCR) after definitive local therapy remains a major clinical challenge in prostate cancer (PCa), with heterogeneous disease trajectories and few established strategies...
392
Islam Elkholi @iselkholi.bsky.social · 09/08/2025
I am very grateful to CCS for not only supporting my fellowship work but also investing in my career development and being part of academic journey!
010
Islam Elkholi @iselkholi.bsky.social · 27/05/2025
Excited to share our latest discovery just published in Cancer Research. lnkd.in/e_vNXXJC ⭐ We revealed that dormancy-prone or dormant breast cancer (BC) cells might be eliminated by targeting PIK3C3 (the 3rd class PI3K), hence less #metastasis burden in #breastcancer. @jf-cotelab.bsky.social
221
Reposted by Islam Elkholi
Aguirre-Ghiso Lab @jaguirreghisolab.bsky.social · 20/05/2025
New vulnerability of dormant breast cancer cells dependent on a specific isoform of PI3K revealed by Islam Elkholi, JF Cote and team @ircm.bsky.social. Really happy to see this paper out and to have been of service! aacrjournals.org/cancerres/ar...
aacrjournals.org
Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis Initiation
Abstract. Halting breast cancer metastatic relapse following primary tumor removal remains challenging due to a lack of specific vulnerabilities to target during the clinical dormancy phase. To identi...
1102
Islam Elkholi @iselkholi.bsky.social · 08/05/2025
After 1 year of preparation! #Done
010
Islam Elkholi @iselkholi.bsky.social · 02/04/2025
www.youtube.com/watch?v=MhY7...
youtube.com
Eydís Evensen - Full Performance (Live on KEXP at Home)
YouTube video by KEXP
000
Islam Elkholi @iselkholi.bsky.social · 02/04/2025
Repainting the sky..
110
Islam Elkholi @iselkholi.bsky.social · 27/03/2025
Glad to announce the 1st Basic & Clinical Oncology (BCO) conference on May 7 at the IRCM/Montreal as a partnership between 9 institutes/networks across Quebec! Clinical and basic cancer research abstracts are welcome (deadline April 6). More details: www.ircm.qc.ca/en/events/de... #Montreal #Quebec
143
Reposted by Islam Elkholi
Québec Science @quebecscience.bsky.social · 13/03/2025
🌕🌖🌗🌘🌑🌒🌓🌔Surveillez le ciel dans la nuit du 13 au 14 mars : une éclipse totale de Lune sera au rendez-vous! Cet événement astronomique sera visible depuis le Québec et débutera à 1 h 09 pour se terminer à 4 h 47. L’éclipse atteindra son apogée entre 2 h 59 et 3 h 31. Voici notre photo prise en 2015.
Éclipse lunaire totale de 2015 dans la région de Montréal.
1143
Reposted by Islam Elkholi
Gomes Lab @gomeslab.bsky.social · 03/02/2025
So happy to share the newest pre-print from the lab where we show that old age significantly changes the traits that evolve in established lung adenocarcinoma. This work sheds light into the importance of modeling age-related cancers in the context of old age. www.biorxiv.org/content/10.1...
biorxiv.org
Aging directs the differential evolution of KRAS-driven lung adenocarcinoma
Lung adenocarcinoma (LUAD), the most common histological subtype of lung cancer( [1][1], [2][2] ), is a disease of the elderly, with an average age of diagnosis of about 70 years of age( [3][3] ). Old...
1175
Islam Elkholi @iselkholi.bsky.social · 03/02/2025
Join us this Thursday on Zoom. Basic and Clinical Oncology Bench ↔️ Bedside Seminar Series. #cancer #oncology
000
Reposted by Islam Elkholi
Anshul Kundaje @anshulkundaje.bsky.social · 24/01/2025
I wanted to write briefly about a very pleasant experience we recently had coordinating and collaborating closely on competing publications with 2 other teams. 1/
211523
Islam Elkholi @iselkholi.bsky.social · 18/11/2024
Kicking off with sharing our latest discussion on breast cancer dormancy & how to bridge the gap between the bench & bedside! tinyurl.com/msctvab2 P.S. I post about metastasis/signaling, Jazz/Egyptian classics & interesting reads. Looking fwd to connecting with people disseminating from Twitter 😊
020